GenSight Biologics S.A.
GenSight Biologics S.A. (GSGTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GSGTF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGenSight Biologics S.A. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
BiotechnologyCompare GSGTF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income GenSight Biologics S.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
GenSight Biologics S.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from GenSight Biologics S.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GSGTF revenue · 4 questionsGSGTF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · GenSight Biologics S.A. SEC filings · GAAP · GenSight Biologics S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026